If your sleep is broken because your airway keeps closing, a sedative does not open your airway. It makes you less aware of a problem that is still happening. That is the core of the argument, and it does not depend on whether the tablet makes the apnoea measurably worse on the night: an untreated airway disorder carries consequences that accumulate whether or not you notice the interruptions. This is why every patient at Slumbr is screened for sleep apnoea before any sedating treatment is considered, and why a sleep study sometimes has to come before a prescription.
Key takeaways
- The main danger is masking. Sedation can smooth over the symptom while the underlying obstruction, and its cardiovascular consequences, continue untreated.
- The evidence on whether sedatives directly worsen apnoea is more mixed than commonly stated, and differs by drug class.
- For benzodiazepines specifically, one large database study found a higher risk of adverse respiratory events in people with sleep apnoea. Non-benzodiazepine hypnotics did not show the same association in that study.
- Alcohol is the sedative most people overlook, and its effect on the airway is not in doubt.
- CBT-I is first-line for chronic insomnia regardless, and it carries no respiratory risk at all.
The problem with treating a symptom you have misidentified
Someone sleeping badly, waking unrefreshed and dragging through the day has a real complaint. If they present asking for something to help them sleep, and nobody asks about snoring or witnessed breathing pauses, the obvious move is to treat the insomnia.
But those symptoms are also exactly how obstructive sleep apnoea presents. And the treatments diverge completely. Apnoea needs the airway held open, usually with CPAP, or the anatomy or position addressed. It does not need sedation, and sedation does not touch the mechanism.
What sedation can do is make the person feel that something has been done. They stop investigating. The apnoea continues, night after night, along with the oxygen swings and sympathetic surges that connect it to high blood pressure. That delay is the harm, and it is the harm that a screening question would have prevented.
What the evidence actually says, by class
We want to be precise here, because this topic attracts more confident writing than the evidence supports.
Benzodiazepines. These carry the clearest signal. A study using Taiwan's national health insurance database compared people with sleep apnoea who developed pneumonia or acute respiratory failure against matched sleep apnoea patients who did not. Recent benzodiazepine use was independently associated with a higher risk of these adverse respiratory events, with an adjusted odds ratio of 2.70 (95% confidence interval 1.15 to 6.33).
The caveats are real and worth stating: this was a retrospective database study, not a trial. The population was predominantly Taiwanese. Sleep apnoea severity was not available from the registry codes, so we cannot tell who was mild and who was severe. It shows an association, not a mechanism proven in individuals. But it is a large, adjusted, clinically coherent signal in exactly the direction the pharmacology would predict, and it is enough to justify caution.
Non-benzodiazepine hypnotics, the so-called z-drugs. In that same study, these did not show an increased risk of adverse respiratory events. The wider physiological literature is more mixed than the popular account suggests. At standard doses they have not been shown to systematically reduce the activity of the muscles that hold the upper airway open. They do raise the threshold at which a breathing disturbance wakes you, and, counterintuitively, that is not uniformly bad: in some people the arousals themselves destabilise breathing control, and there is research suggesting the effect on apnoea severity can go either way depending on the individual's physiology.
So we are not going to tell you that z-drugs worsen sleep apnoea. What we will tell you is that they do not treat it, that the person taking one for undiagnosed apnoea is still not being treated for the actual disorder, and that "probably not directly harmful" is a poor reason to leave a diagnosis unmade.
Sedating antihistamines, widely available and widely used as informal sleep aids, deserve their own caution. They are sedating without being good at producing quality sleep, tolerance to the sedative effect develops quickly, and the daytime residue can be substantial. We do not have outcome data showing they worsen measured apnoea severity, and we are not going to claim it. They remain a poor tool for a problem that has not been diagnosed.
Alcohol. The one nobody counts as a sedative. It relaxes upper airway muscle tone, and its effect on snoring and breathing events is well recognised and dose-related. If you are investigating disturbed sleep, evening alcohol is one of the most useful things to change while you wait for answers.
Why we screen before we prescribe
Slumbr's clinical formulary makes a sleep apnoea screen mandatory before any sedating agent is considered. That is not defensive box-ticking, it is the logic of the two paragraphs above: the same presentation can be two different disorders, and one of them gets worse if you treat it as the other.
In practice this means:
- Every patient is screened, through the Sleep Pattern Assessment and again in consultation. Snoring, witnessed pauses, gasping awake, daytime sleepiness, blood pressure, neck circumference and body mass all feed into it.
- A high-risk screen means testing before treatment. If sleep apnoea is likely, the next step is a sleep study, not a prescription.
- If apnoea is confirmed, it gets treated as apnoea. Insomnia occurring alongside it is then addressed on its own terms, most often behaviourally, sometimes with medication, but always with the airway accounted for.
Patients occasionally find this frustrating, particularly when they have been sleeping badly for years and want relief now. The honest response is that the delay is usually days to weeks, and the alternative is a treatment aimed at the wrong target.
What we would do instead
Cognitive behavioural therapy for insomnia is first-line for chronic insomnia, ahead of any medication, in every major guideline. It has no respiratory risk, which makes it the safe option even while apnoea status is unknown. It is also the treatment with the most durable results, which tends to get lost in the discussion about tablets. We cover it in CBT-I in South Africa.
Alongside that, and available immediately: move alcohol earlier in the evening or reduce it, try side sleeping rather than back sleeping, and address nasal congestion if it is present. None of these are dramatic. All of them are safe to do before you know your diagnosis, and all of them help either condition.
If sleep apnoea is excluded and chronic insomnia is confirmed, medication may then have a legitimate short-term role alongside behavioural treatment. That is a decision made with a diagnosis in hand rather than instead of one.
Frequently asked questions
Can I take sleeping tablets if I have sleep apnoea? It depends on the drug class, the severity of your apnoea, and whether the apnoea is being treated. Benzodiazepines have been associated with a higher risk of adverse respiratory events in people with sleep apnoea and are generally best avoided. Any sedative in this situation is a decision for the doctor who knows your diagnosis, not a self-directed one.
Why does my doctor want a sleep study before prescribing anything? Because sleep apnoea and insomnia can look identical from the outside, and they need opposite treatments. Sedating an undiagnosed airway problem leaves the real disorder untreated while making it less noticeable. The study is what tells your doctor which problem they are actually treating.
Do sleeping tablets make sleep apnoea worse? Less clear-cut than is often claimed, and it varies by class. Benzodiazepines carry the clearest concern. Non-benzodiazepine hypnotics have not shown the same association with adverse respiratory events, and their effect on apnoea severity appears to depend on the individual. The stronger argument is not that they worsen it, but that they do not treat it.
What about alcohol as a sleep aid with sleep apnoea? Alcohol relaxes the muscles that keep the upper airway open, and it reliably worsens snoring and breathing events. It also fragments the second half of the night. As a sleep aid in someone with suspected or confirmed sleep apnoea, it is a poor choice.
I have been on sleeping tablets for years and I snore. What should I do? Raise both facts with a doctor together, because that combination is worth assessing properly. Do not stop prescribed medication abruptly on your own, particularly with longer-term use, since some sedatives require a planned taper. Ask for a sleep apnoea screen and take it from there.
This article is educational and is not a diagnosis or a substitute for medical advice. Never start or stop prescribed medication without speaking to your doctor. Slumbr does not provide emergency care. If you are in crisis, seek urgent in-person help.
Sleeping badly, snoring, and wondering what is actually wrong? Take the free Slumbr Sleep Pattern Assessment™, which screens for sleep apnoea before it suggests anything else. Or book an online consultation with a specialist physician.